Minerva Neurosciences, Inc. (NERV)
NASDAQ: NERV · Real-Time Price · USD
1.540
-0.090 (-5.52%)
At close: May 14, 2025, 4:00 PM
1.500
-0.040 (-2.60%)
After-hours: May 14, 2025, 4:08 PM EDT
Minerva Neurosciences Employees
Minerva Neurosciences had 8 employees as of December 31, 2024. The number of employees decreased by 1 or -11.11% compared to the previous year.
Employees
8
Change (1Y)
-1
Growth (1Y)
-11.11%
Revenue / Employee
n/a
Profits / Employee
$781,837
Market Cap
10.77M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
NERV News
- 1 day ago - Minerva Neurosciences Reports First Quarter 2025 Financial Results and Business Updates - GlobeNewsWire
- 2 months ago - Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Business Updates - GlobeNewsWire
- 6 months ago - Minerva Neurosciences Reports Third Quarter 2024 Financial Results and Business Updates - GlobeNewsWire
- 1 year ago - Minerva Neurosciences Reports First Quarter 2024 Financial Results and Business Updates - GlobeNewsWire
- 1 year ago - US FDA declines to approve Minerva Neurosciences' schizophrenia drug - Reuters
- 1 year ago - Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Business Updates - GlobeNewsWire
- 1 year ago - Minerva Neurosciences Reports 2023 Third Quarter Financial Results and Business Updates - GlobeNewsWire
- 1 year ago - Minerva Neurosciences: There's Probably Time For One More Rally - Seeking Alpha